CN1850078A - 一种抗血小板凝集药物注射液及其制备方法 - Google Patents
一种抗血小板凝集药物注射液及其制备方法 Download PDFInfo
- Publication number
- CN1850078A CN1850078A CN 200610013082 CN200610013082A CN1850078A CN 1850078 A CN1850078 A CN 1850078A CN 200610013082 CN200610013082 CN 200610013082 CN 200610013082 A CN200610013082 A CN 200610013082A CN 1850078 A CN1850078 A CN 1850078A
- Authority
- CN
- China
- Prior art keywords
- injection
- water
- glucose
- recipe quantity
- platelet aggregation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
样品1 | 样品2 | 样品3 | |||||||||||||
检查项目 | 0个月 | 1个月 | 2个月 | 3个月 | 6个月 | 0个月 | 1个月 | 2个月 | 3个月 | 6个月 | 0个月 | 1个月 | 2个月 | 3个月 | 6个月 |
含量(%) | 99.8 | 99.6 | 99.5 | 99.7 | 99.8 | 99.5 | 99.7 | 99.2 | 99.4 | 99.4 | 99.5 | 99.7 | 99.6 | 99.8 | 99.7 |
有关物质(%) | 0.14 | 0.15 | 0.17 | 0.13 | 0.14 | 0.13 | 0.16 | 0.17 | 0.15 | 0.18 | 0.16 | 0.14 | 0.13 | 0.14 | 0.15 |
可见异物 | 合格 | 合格 | 合格 | 合格 | 合格 | 合格 | 合格 | 合格 | 合格 | 合格 | 合格 | 合格 | 合格 | 合格 | 合格 |
检查项目 | 样品1 | 样品2 | 样品3 | ||||||
0个月 | 12个月 | 24个月 | 0个月 | 12个月 | 24个月 | 0个月 | 12个月 | 24个月 | |
>10μm(个/ml) | 5.5 | 6.9 | 10.1 | 5.8 | 8.0 | 11.5 | 5.7 | 8.2 | 11.7 |
>20μm(个/ml) | 0.2 | 0.7 | 1.0 | 0.5 | 0.8 | 1.2 | 0.4 | 0.9 | 1.2 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100130829A CN1850078B (zh) | 2006-01-20 | 2006-01-20 | 一种抗血小板凝集药物注射液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100130829A CN1850078B (zh) | 2006-01-20 | 2006-01-20 | 一种抗血小板凝集药物注射液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1850078A true CN1850078A (zh) | 2006-10-25 |
CN1850078B CN1850078B (zh) | 2010-09-08 |
Family
ID=37131590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100130829A Expired - Fee Related CN1850078B (zh) | 2006-01-20 | 2006-01-20 | 一种抗血小板凝集药物注射液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1850078B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101368897B (zh) * | 2008-09-08 | 2011-01-26 | 西王集团有限公司 | 无水葡萄糖滤膜滤速检测方法 |
CN110988158A (zh) * | 2019-11-25 | 2020-04-10 | 鲁南制药集团股份有限公司 | 一种盐酸替罗非班注射液有关物质的检测方法 |
CN111937858A (zh) * | 2020-07-06 | 2020-11-17 | 晶准生物医学(深圳)有限公司 | 抗凝组合物、真空采血管 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1322863C (zh) * | 2004-10-29 | 2007-06-27 | 武汉远大制药集团股份有限公司 | 一种抑制血小板凝聚的注射液及其制备方法 |
CN100386079C (zh) * | 2005-03-24 | 2008-05-07 | 武汉远大制药集团股份有限公司 | 一种抑制血小板凝聚的注射用粉针及其制备方法 |
-
2006
- 2006-01-20 CN CN2006100130829A patent/CN1850078B/zh not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101368897B (zh) * | 2008-09-08 | 2011-01-26 | 西王集团有限公司 | 无水葡萄糖滤膜滤速检测方法 |
CN110988158A (zh) * | 2019-11-25 | 2020-04-10 | 鲁南制药集团股份有限公司 | 一种盐酸替罗非班注射液有关物质的检测方法 |
CN111937858A (zh) * | 2020-07-06 | 2020-11-17 | 晶准生物医学(深圳)有限公司 | 抗凝组合物、真空采血管 |
Also Published As
Publication number | Publication date |
---|---|
CN1850078B (zh) | 2010-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1138541C (zh) | 一种药学上稳定的奥沙利铂制剂 | |
CN101411710B (zh) | 培美曲塞二钠冻干粉针剂及其制备方法 | |
BE1026546B1 (fr) | Solution intraveineuse d'acide tranexamique prete a l'emploi | |
CN1850078A (zh) | 一种抗血小板凝集药物注射液及其制备方法 | |
CN101874770A (zh) | 一种克林霉素磷酸酯注射液及其制备方法 | |
CN102600072B (zh) | 盐酸替罗非班注射液及其制备方法 | |
CN1572296A (zh) | 长春西汀冻干粉针制剂及其制备工艺 | |
CN102018677A (zh) | 注射用盐酸罗沙替丁醋酸酯及其制备方法 | |
CN102038680B (zh) | 一种药用组合物 | |
CN1830440A (zh) | 一种甲硝唑注射液及其制备方法和用途 | |
CN101053557A (zh) | 重酒石酸去甲肾上腺素药物组合物冻干粉针注射剂 | |
CN1231223C (zh) | 灯盏花素输液制剂及其制备方法 | |
CN1686127A (zh) | 一种抑制血小板凝聚的注射用粉针及其制备方法 | |
CN1371284A (zh) | 多剂量红细胞生成素制剂 | |
CN1230175C (zh) | 注射用盐酸川芎嗪冻干剂及其制备方法 | |
CN102871961B (zh) | 一种含替罗非班的注射液 | |
CN1634054A (zh) | 一种抑制血小板凝聚的注射液及其制备方法 | |
CN1742725A (zh) | 盐酸替罗非班冻干粉针注射剂及其制备方法 | |
CN103877579B (zh) | 一种含有法莫替丁的药物组合物及其制剂 | |
CN100427095C (zh) | 含有钙通道阻滞药地尔硫䓬稀释后供静脉注射的注射液 | |
CN1830434A (zh) | 一种曲克芦丁注射液的制备方法 | |
US20230285326A1 (en) | Epinephrine formulations | |
CN1732959A (zh) | 注射用盐酸胍甲环素及其制备方法 | |
CN102526042B (zh) | 稳定的液体药物组合物 | |
CN1742717A (zh) | 含有氯旨醒的液体药剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TIBET LINZHI BAISHENG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: NANKAI YUNGONG PHARMACEUTICAL SCIENCE-TECHNOLOGY CO., LTD., TIANJIN Effective date: 20130822 Owner name: NAIKAI SHARE PHARMACEUTICAL CO., LTD. Effective date: 20130822 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 300071 NANKAI, TIANJIN TO: 850400 NYINGCHI PREFECTURE, TIBET AUTONOMOUS REGION |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130822 Address after: 850400 Tibet autonomous region Linzhi region Biotechnology Industry Park Patentee after: Tibet Linzhi Baisheng Pharmaceutical Co., Ltd. Patentee after: Naikai Share Pharmaceutical Co., Ltd. Address before: 300071 teaching instrument building, Southwest Village, Nankai University, Tianjin Patentee before: Nankai Yungong Pharmaceutical Science-Technology Co., Ltd., Tianjin |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 850000 Tibet autonomous region Linzhi region Biotechnology Industry Park Patentee after: Tibet Linzhi Baisheng Pharmaceutical Co., Ltd. Patentee after: Tongliao Huabang Pharmaceutical Co Ltd Address before: 850000 Tibet autonomous region Linzhi region Biotechnology Industry Park Patentee before: Tibet Linzhi Baisheng Pharmaceutical Co., Ltd. Patentee before: Naikai Share Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100908 Termination date: 20190120 |
|
CF01 | Termination of patent right due to non-payment of annual fee |